MedTrace Logo

A Multi-center Long Term Efficacy Trial of the GFX For Reduction of Glabellar Furrowing

NCT00611273 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2014-06-24

No results posted yet for this study

Summary

Long term efficacy study of GFX for patients undergoing reduction of glabellar furrowing

Conditions

  • Glabellar Furrowing

Interventions

DEVICE

GFX

The GFX system employs minimally invasive technique utilizing Bi-polar (radio frequency) RF technology. GFX ablates nerves activating the muscles that cause glabellar furrowing.

Sponsors & Collaborators

  • Advanced Cosmetic Intervention

    lead INDUSTRY

Principal Investigators

  • James Newman, MD · Premier Plastic Surgery

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2008-04-30
Completion
2008-04-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00611273 on ClinicalTrials.gov